Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amgen, Apellis, Ascendis, Beigene, Carsgen, Celltrion, Chemocentryx, Coherus, Eli Lilly, Galapagos, Gannex, Hebabiz, Hyloris, Innocare, Junshi, Kyowa Kirin, Mimivax, Moderna, Newbridge, Novavax, Novo, Nrx, Nurix, Pharmaessentia, Regeneron, Relief, Rhythm, Roche, Sanofi, SK Bioscience, Vertex, Viridian.